Biotoxtech Co., Ltd. (KOSDAQ:086040)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
R&D Services	41.34B	32.63B	37.29B	32.72B	-
R&D Services Growth	26.69%	-12.50%	13.98%	-	-
Total	41.34B	32.63B	37.29B	32.72B	-
Total Growth	26.69%	-12.50%	13.98%	-	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
South Korea	35.43B	30.22B	36.04B	31.27B	24.88B
South Korea Growth	17.23%	-16.14%	15.27%	25.65%	1.33%
Overseas	5.91B	2.41B	1.25B	1.45B	1.54B
Overseas Growth	145.61%	92.24%	-13.70%	-6.04%	19.13%
Total	41.34B	32.63B	37.29B	32.72B	26.43B
Total Growth	26.69%	-12.50%	13.98%	23.80%	2.22%

Source: S&P Global Market Intelligence.